Lithium can be toxic if not used properly. Further, the research is still in the early stages and it is unlikely that a ...

While our understanding of Alzheimer’s disease is far from complete, the latest therapies, and others in more than 100 ...

New research suggests that lithium is depleted in the brains of Alzheimer's patients and is essential for normal brain ...

The US Food and Drug Administration (FDA) has approved a new version of an Alzheimer’s disease drug that can be given as a ...

A new generation of Alzheimer’s blood tests could speed up diagnosis and access to care—but they also raise thorny questions ...

When Juli comes home after work, her husband doesn’t regale her with stories about his photography business the way he once ...

Coya's COYA 303 showed strong immune modulation and reduced inflammation in the brain, supporting its development for ...

Ascension became the first provider in Wisconsin to administer Kisunla, a new FDA-approved drug for Alzheimer’s, which is ...

The anti-amyloid maintenance therapy offers a once-weekly, subcutaneous option after 18 months of intravenous treatment.

Alzheimer’s disease is a progressive neurodegenerative disease that affects an individual’s behavior, memory, and mental capabilities. Alzheimer’s allows for the build-up of proteins in the brain, ...

The combination of a recently approved blood test for the detection of Alzheimer’s disease, combined with two medications that slow the progression of the disease, is drastically improving outcomes ...

The Wasatch Back Alzheimer's Association chapter hosted its annual Walk to End Alzheimer’s Saturday, Sept. 6. The group’s ...